Stay updated on Nemvaleukin+Pembrolizumab in Platinum-Resistant Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Nemvaleukin+Pembrolizumab in Platinum-Resistant Ovarian Cancer Clinical Trial page.

Latest updates to the Nemvaleukin+Pembrolizumab in Platinum-Resistant Ovarian Cancer Clinical Trial page
- Check7 days agoChange DetectedThe page has been updated to reflect a new version (v2.16.5) and indicates that results have been submitted, while previous information about the modernization of ClinicalTrials.gov data ingest and the absence of results has been removed.SummaryDifference5%
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference4%
- Check28 days agoNo Change Detected
- Check36 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.3%
- Check43 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference6%
- Check71 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.3%
- Check85 days agoChange DetectedThe web page has been updated to reflect a new version, changing from v2.14.4 to v2.15.0.SummaryDifference1.0%
Stay in the know with updates to Nemvaleukin+Pembrolizumab in Platinum-Resistant Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nemvaleukin+Pembrolizumab in Platinum-Resistant Ovarian Cancer Clinical Trial page.